These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7011064)

  • 1. Questioning a dopaminergic hypothesis.
    Langer DH; Rapoport JL; Brown GL; Ebert MH; Bunney WE
    Am J Psychiatry; 1981 Apr; 138(4):537-8. PubMed ID: 7011064
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral effects of carbidopa/levodopa in hyperactive boys.
    Langer DH; Rapoport JL; Brown GL; Ebert MH; Bunney WE
    J Am Acad Child Psychiatry; 1982 Jan; 21(1):10-8. PubMed ID: 7047618
    [No Abstract]   [Full Text] [Related]  

  • 3. An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction.
    Reimherr FW; Wood DR; Wender PH
    Am J Psychiatry; 1980 Jan; 137(1):73-5. PubMed ID: 6986093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levodopa on attention deficit disorder, residual type.
    Wood D; Reimherr F; Wender PH
    Psychiatry Res; 1982 Feb; 6(1):13-20. PubMed ID: 6949167
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis.
    Oren DA; Moul DE; Schwartz PJ; Wehr TA; Rosenthal NE
    J Clin Psychopharmacol; 1994 Jun; 14(3):196-200. PubMed ID: 8027416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral levodopa and carbidopa on coronary spasm in variant angina pectoris.
    Bugiardini R; Morgagni G; Pozzati A; Ottani F; Borghi A; Lenzi S; Puddu P
    Am J Cardiol; 1987 Sep; 60(7):489-93. PubMed ID: 3630930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine metabolism in the attention deficit disorder: implications for the use of amino acid precursor therapy.
    McConnell H
    Med Hypotheses; 1985 Aug; 17(4):305-11. PubMed ID: 4046902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Simpson GM; Yadalam KG; Stephanos MJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tyrosine on attention deficit disorder with hyperactivity.
    Eisenberg J; Asnis GM; van Praag HM; Vela RM
    J Clin Psychiatry; 1988 May; 49(5):193-5. PubMed ID: 3284877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH; Odin P
    Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.
    Reimherr FW; Wender PH; Wood DR; Ward M
    Am J Psychiatry; 1987 Aug; 144(8):1071-3. PubMed ID: 3300376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.
    Mooney ME; Schmitz JM; Moeller FG; Grabowski J
    Drug Alcohol Depend; 2007 May; 88(2-3):214-23. PubMed ID: 17134849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder.
    Malone MA; Kershner JR; Swanson JM
    J Child Neurol; 1994 Apr; 9(2):181-9. PubMed ID: 8006372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
    Napolitano A; Bonuccelli U; Rossi B
    Eur Neurol; 1997; 38(2):119-22. PubMed ID: 9286635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa/carbidopa/entacapone in Parkinson's disease.
    Seeberger LC; Hauser RA
    Expert Rev Neurother; 2009 Jul; 9(7):929-40. PubMed ID: 19589043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbidopa levodopa enteral suspension.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2015; 16(18):2807-17. PubMed ID: 26595228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining.
    Gonon F
    Trends Neurosci; 2009 Jan; 32(1):2-8. PubMed ID: 18986716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.